Skip to content

Advertisement

Retrovirology

  • Research
  • Open Access

Transactivation of elements in the human endogenous retrovirus W family by viral infection

  • 1Email author,
  • 1,
  • 2,
  • 3,
  • 2 and
  • 1
Retrovirology20063:44

https://doi.org/10.1186/1742-4690-3-44

©  Nellåker et al; licensee BioMed Central Ltd. 2006

Received: 31 March 2006

Accepted: 06 July 2006

Published: 06 July 2006

Abstract

Background

Aberrant expression of human endogenous retrovirus (HERV) elements in the W family has previously been associated with schizophrenia, multiple sclerosis and preeclampsia. Little is know regarding the basal expression, transcriptional regulation and functional significance of individual HERV-elements. Since viral infections have previously been reported to transactivate retroviral long terminal repeat regions we examined the basal expression of HERV-W elements and following infections by influenza A/WSN/33 and Herpes simplex 1 viruses in human cell-lines.

Methods

Relative levels of transcripts encoding HERV-W elements and cellular genes were analyzed by qPCR methods. An analysis of amplicon melting temperatures was used to detect variations in the frequencies of amplicons in discrete ranges of such melting temperatures. These frequency-distributions were taken as proxy markers for the repertoires of transcribed HERV-W elements in the cells.

Results

We report cell-specific expression patterns of HERV-W elements during base-line conditions. Expressed elements include those with intact regulatory long terminal repeat regions (LTRs) as well as elements flanked by truncated LTRs. Subsets of HERV-W elements were transactivated by viral infection in the different cell-lines. Transcriptional activation of these elements, including that encoding syncytin, was dependent on viral replication and was not induced by antiviral responses. Serum deprivation of cells induced similar changes in the expression of HERV-W elements suggesting that the observed phenomena are, in part, an effect of cellular stress.

Conclusion

We found that HERV-W elements, including elements lacking regulatory LTRs, are expressed in cell-specific patterns which can be modulated by environmental influences. This brings into light that mechanisms behind the regulation of expression of HERV-W elements are more complex than previously assumed and suggests biological functions of these transcripts.

Keywords

  • Influenza
  • U937 Cell
  • 293F Cell
  • Long Terminal Repeat Region
  • Terminal Repeat Region

Background

Human endogenous retroviruses (HERV) are assumed to be remnants of ancient retroviral infections of our ancestors' germ-line cells. HERV sequences constitute approximately 3–8% of the human genome and can be classified into at least 31 families [1, 2]. Tissue-specific hybridization patterns toarrays of sequences representative of different HERV families was recently reported, indicating a discrete and diversified regulation of their transcriptional activities [3, 4].

The differential detection of pol transcripts related to one of these families, HERV-W [5], was previously observed in cerebrospinal fluids obtained from patients with multiple sclerosis [6] and patients experiencing their first manifestations of schizophrenia or schizoaffective disorder [7] as compared to control individuals. A recent study reported similar hybridization signals to a HERV-W pol sequence in prefrontal cortex samples from postmortem brains from patients with a long standing history of schizophrenia or bipolar disorder and control individuals [8].

According to Pavlicek et.al. [9] the human genome contains 654 HERV-W elements, the majority of which are comprised of long terminal repeat regions (LTR) lacking internal sequence. The remaining elements were classified into 2 major categories, a total of 77 retroelements with proviral structure containing intact LTRs and complete or partial internal sequences (gag, pol and env genes). In addition, 149 pseudoelements with internal sequences were found, lacking the regulatory U3 region of the 5'-LTR and the U5 region of the 3'-LTR. Structurally these copies resemble retroviral mRNAs and are thought to originate from LINE-mediated reverse transcription of such mRNAs. The remaining elements were grouped together in a third category based on lack of diagnostic regions due to truncations [9]. Due to the absence of regulatory promoter regions, these latter groups have been suggested to be non-transcribed [9, 10]. However, except for a proviral element in ERVWE1 locus, which contains an intact env gene encoding syncytin [11], basal transcriptional activities of individual HERV-W elements remain poorly defined. Furthermore, potential regulation of individual HERV-W element expression is even less studied.

Herpes simplex viruses are known to transactivate retroviral regulatory LTR regions of both exogenous and endogenous human retroviruses, reviewed in [12]. With regard to HERV-W elements, induction of protein expression by HSV-1 was recently reported [13]. Although Influenza A virus has in one study been reported to transactivate the HIV-1 LTR [14], the influence RNA viruses on the transcriptional activities of HERV-W elements has, however, not been studied. Consequently we investigated the transcriptional activities of different HERV-W elements in human cell-lines during baseline conditions and how these are modulated by viral infections.

Results

Virus infection transactivates HERV-W elements

Initially, the neuroepithelioma cell-line (SK-N-MC) was infected with increasing titers of herpes simplex virus 1 (HSV-1) or influenza A/WSN/33 viruses. 24 or 48 hours post infection, the levels of transcripts from the latency gene 1 of HSV-1 and segment 8 of the influenza A/WSN/33 virus genomes were proportional to the respective numbers of viral plaque forming units (pfu) added to the cultures as determined by quantitative real-time PCR (Figure 1A and Figure 1B). Linear regression analyses revealed dose-dependent elevations of the relative levels of transcripts from HERV-W related gag and env genes elements 24 hours after infection with HSV-1 (Figure 1A). Cells infected with influenza A/WSN/33 virus responded with a dose-dependent increase in the relative levels of HERV-W env, but not gag, transcripts (Figure 1B). Reverse transcriptase controls were consistently found to be negative (data not shown). Variations in the levels of transcripts encoding IFN-β appeared to correlate with those from HERV-W env elements in response to both HSV-1 and influenza A/WSN/33 infections. By these experiments we were thus able to confirm the previous studies reporting induction of HERV-W by HSV-1 and make the novel observation that also influenza A/WSN/33 virus infection can transactivate HERV-W elements. In following experiments, 106 pfus of the influenza A/WSN/33 virus were used, corresponding to 0.5 multiplicity of infection (MOI).
Figure 1
Figure 1

Gene expression in infected SK-N-MC cells. Relative levels of transcripts from HERV-W env, HERV-W gag and IFNB1 in SK-N-MC cells infected with increasing doses of herpes simplex type 1 (A) or influenza A/WSN/33 (B) as compared to uninfected control cell-cultures. Relative levels of transcripts from the US6 gene of herpes simplex type 1 (A) and segment 8 of the influenza A/WSN/33 virus strain (B) were determined in infected cultures. Relative levels of viral transcripts were normalized to those observed in cells infected with the lowest dose of each virus (n controls = 4, n virus = 5).

We next investigated if similar effects of the influenza A virus infection could be observed in other human cell-lines. The subsequent experiments were therefore conducted on the human astrocytoma cell-line, CCF-STTG1, the human histiocytic lymphoma cell-line U937, as well as 293F cells derived from human kidney. At baseline, all these cell-types contained detectable levels of transcripts from both HERV-W gag and env genes. Such transcripts were detected at significantly elevated levels in all three cell-types 24 hrs after infection (Figure 2A). U937 cells exhibited the highest relative increase in the levels of these transcripts.
Figure 2
Figure 2

Expression of HERV-W elements in human cell-lines following influenza A/WSN/33 virus infection (A) or serum deprivation (B). CCF-STTG1, 293F and U937 cells infected with influenza A/WSN/33 virus (n = 7-9) were analyzed for HERV-W related transcripts relative to uninfected control cells (n = 7-12). Cells deprived of serum (n = 5-7) were analyzed for HERV-W related transcripts relative to control cells in serum enriched culture media (n = 5-8). Error bars indicate the standard error of the difference between the means of infected or serum deprived cells and corresponding control cells. Statistical significance is indicated by * = p < 0.05, ** = p < 0.01, *** = p < 0.001.

Relative increases in HERV-W element transcription after serum deprivation

Since influenza A viruses induce the expression of a variety of cytokine and pro-apoptotic genes in infected cells, we next investigated the levels of HERV-W transcripts in response to double-stranded RNA or replication-incompetent virus. CCF-STTG1 cultures were therefore exposed to poly(cytidylic-inosinic) acid (poly(I:C)) to activate protein kinase R (PKR) or heat-inactivated influenza A/WSN/33 virus to simulate effects of viral binding and fusion in the absence of viral replication. Poly(I:C)-treatment elicited a 33-fold increase in the levels of transcripts encoding IFN-β indicating adequate stimulation (data not shown). However, no significant alterations in the relative levels of HERV-W transcripts were observed in cells treated with poly(I:C) or heat-inactivated virus as compared to untreated controls (data not shown). In addition to mechanisms mediated by PKR, influenza A virus infections can induce apoptosis in infected cells by complex mechanisms not yet fully understood [15]. We next serum deprived the different cell-lines to induce stresses including cellular events leading to apoptosis [16–18]. CCF-STTG1 cells showed a small but significant increase only in the levels of env transcripts after serum deprivation. Serum deprived U937 cells exhibited significantly elevated levels of both HERV-W gag and env transcripts whereas the expression of these transcripts remained at baseline levels in 293F cells (Figure 2B). Thus, induction of HERV-W expression by influenza A/WSN/33 virus appears to be, at least partially, an effect of events leading to apoptosis during infection. Whether the relatively larger responses observed in infected cells as compared with serum deprived cells stems from additional actions of viral proteins or cellular responses to viral load remains undetermined.

Qualitative analysis of HERV-W env and gagexpression

We observed variations in Tm's of transcripts amplified in the assays for HERV-W gag and env in response to infection or serum deprivation and between controls of the different cell-lines. This was taken to be indicators of sequence variations and cloning and sequencing of amplicons from each of the different Tm categories supported this view (sequences and Tm's, Table 2). Sequenced products showed the greatest homology to previously identified HERV-W sequences in all cases as determined by BLAST http://www.ncbi.nlm.nih.gov/BLAST/ analyses. However, while each sequence was only detected in one Tm category, every Tm category encompassed multiple sequences. Thus, we conducted analyses of frequency distribution of amplicons into distinguishable HERV-W gag and env Tm categories (Figure 3A and 3B respectively) and compared these distributions between control, virus infected and serum deprived cells. The frequency distribution of HERV-W gag amplicons in four different temperature ranges differed significantly between control and influenza A/WSN/33 infected CCF-STTG1 and U937, but not 293F, cells (CCF-STTG1 χ2 = 32.09, df = 3, p < 0.0001, U937 χ2 = 8.523, df = 3, p = 0.0363). Differences were also observed between control and serum deprived CCF-STTG1 and 293F cells (CCF-STTG1 χ2 = 14.86, df = 3, p = 0.0019, 293F χ2 = 14.73, df = 3, p = 0.0021). Significant differences were observed between influenza A/WSN/33 infected and serum deprived 293F and U937 cells (293F χ2 = 17.22, df = 3, p = 0.0006, U937 χ2 = 20.63, df = 3, p < 0.0001). Frequency distributions of HERV-W env amplicons differed significantly between control, infected and starved CCF-STTG1 cells (controls and influenza A/WSN/33 infected samples χ2 = 34.42, df = 2, p < 0.0001, controls and serum deprived cells χ2 = 12.05, df = 2, p = 0.0024, influenza A/WSN/33 infected and serum deprived samples χ2 = 28.44, df = 2, p < 0.0001). The Tm distributions of HERV-W env amplicons did, however, not differ between control, infected or serum deprived samples of either 293F or U937 cells.
Figure 3
Figure 3

Influence of influenza A/WSN/33 virus infection and serum deprivation on the detectable frequency distribution of transcribed HERV-W related sequences in CCF-STTG1, 293F and U937 cells. (A) Distribution of detected HERV-W gag amplicons into four melting temperature ranges observed in control cells (n = 38-44), influenza A/WSN/33 infected cells (n = 24-39) and serum deprived cells (n = 11-18). (B) Distribution of detected HERV-W env amplicons into three melting temperature ranges observed. Statistical significance is indicated by * = p < 0.05, ** = p < 0.01, *** = p < 0.001.

To identify the specific HERV-W elements expressed, all sequences obtained were mapped to the human genome using Blat searches (Table 2). For those sequences without assignment to a unique genomic position, the numbers of homologous matches found are given in Table 2. For unambiguously mapped elements, 5000 upstream bases were subsequently downloaded and subjected to RepeatMasker analyses for the presence of HERV-W related 5'-LTR regions. According to these analyses, one transcribed element on chromosome 1q42 contains an intact HERV-W 5'-LTR whereas three transcribed elements on chromosomes 3q26, 12p13 and 15q21 all have partial HERV-W 5'-LTRs lacking the U3 region. An additional three transcribed elements on chromosomes 5p13, 12p12 and Xq22, however, lack discernible HERV-W 5'-LTRs.

Transactivation of specific HERV-W elements by influenza A virus

To determine if only proviral elements with intact 5'-LTRs or also elements with truncations or deletions in this region were modulated by infection, we specifically assayed the levels of transcripts from a HERV-W proviral element, two pseudoelements, as well as one element devoid of identifiable LTR. We chose to analyze the levels of transcripts from the aforementioned env gene on chromosome 7q21 which is part of a proviral element and encodes the full-length envelope protein, syncytin. Elements on chromosomes 3q26 and 11q13 were selected as examples of HERV-W pseudoelements. The element on 3q26 was unambiguously mapped and has a long ORF capable of encoding a putative matrix and carboxyterminal-truncated capsid proteins [19]. 11q13.5 was, in a different study, identified as differentially expressed in blood cells from recent onset schizophrenia patients (Yao et al, in preparation). Finally, the unambiguously mapped HERV-W element on 5p13 lacks identifiable LTR. Low levels of env-transcripts from the proviral HERV-W element at 7q21 were detected CCF-STTG1 and U937, but not 293F cells at base-line. Following infection, CCF-STTG1 and U937 cells displayed significantly elevated levels of these transcripts (Figure 4). Env-transcripts from this proviral element were also readily detectable in 293F cells following infection, thus indicated by the (∞) symbol in Figure 4. Transcripts from the HERV-W gag gene on 3q26 were detected in all cell types studied at baseline and the levels of these transcripts were significantly elevated (70-fold) in infected U937, but not in CCF-STTG1 or 293F cells. Gag-transcripts from the HERV-W pseudoelement on chromosome 11q13 were also present in all cell-types at baseline but were detected at significantly elevated levels in both 293F and U937 cells following infection. Gag-transcripts from the HERV-W element on 5p13, lacking upstream LTR could not be detected in CCF-STTG1 or 293F cells either at baseline or following infection. U937 cells, however, contained readily detectable levels of 5p13 gag transcripts at baseline and were significantly elevated (64-fold) following infection.
Figure 4
Figure 4

Expression of specific HERV-W elements following influenza A/WSN/33 infection. Levels of transcripts from the HERV-W gag on chromosomes 5p13, 11q13, 3q26 and the HERV-W env ORF encoding syncytin on 7q21 in CCF-STTG1, 293F and U937 cells infected with influenza A/WSN/33 (n = 3-7) relative to uninfected control cells (n = 3-9). Transcripts from 5p13 were not detectable in CCF-STTG1 or 293F cells in either control or infected cells, indicated by nd (not detectable). Syncytin transcripts were not detected in 293F control cells but were readily detectable (ct 34–35 using 500 ng input total RNA) in influenza A/WSN/33 infected cells, resulting in an infinite relative expression as indicated by ∞. Statistical significance is indicated by * = p < 0.05, ** = p < 0.01, *** = p < 0.001.

EZ4U assaying for syncytin mediated cytotoxicity

The transcripts encoding syncytin, found to be transactivated in all cell types studied are normally only found in a cell population in the placenta. To resolve possible functional consequences of ectopic expression of this element CCF-STTG1 cells were transfected with an expression plasmid containing the full-length env gene from 7q21 encoding syncytin. These cells were subsequently assayed for mitochondrial function through the reduction of tetrazolium salts. 24 hours after transfection, 25% less tetrazolium salts were reduced in syncytin-transfected cells as compared to mock-transfected cells (Unpaired t test with Welch's correction P < 0.0001, data not shown). However, as compared to cells over-expressing enhanced GPF, syncytin expression caused a 12% decrease in cell proliferation/viability (Unpaired t test with Welch's correction P = 0.0150).

Discussion

Through melting-temperature differences of amplicons generated using SYBR-Green chemistry followed by cloning and sequencing, we here report the constitutive expression of several different HERV-W elements in human cell-lines. Transcripts from genomic elements with complete, partial as well as absent 5'-LTRs were detected. Furthermore, we report that viral infections in vitro elevate the transcript levels from select HERV-W elements, including elements lacking HERV-W 5'-LTR regulatory regions.

Transcripts from elements in the HERV-W family have previously been detected by RT-PCR in most human organs as well as in different cell-lines of human origin [20]. Transcripts from HERV-W pol genes were recently reported to be present at high levels in the placenta, whole brain, adrenal glands and testis [21]. The relative contribution of the different HERV-W elements to the total levels of pol transcripts in different organs was not examined. The differences in the levels of transcripts from HERV-W gag, pol and env genes observed in different tissues and cell-lines might be attributed to the documented variations in promoter activities of U3-regions of HERV-W LTRs [22, 23]. In addition, enhancer elements outside of the LTR can influence the transcriptional activities of HERV-W LTR promoters. This has been documented for the ERVWE1 locus on chromosome 7q21 which is regulated by promoter activity in the U3 region of the 5'-LTR as well as an upstream regulatory region [24]. Based on our present data there is constitutive, albeit low, expression of various HERV-W elements in human cell-lines. Moreover, the base-line relative transcript levels from different elements appeared to differ between these cell-lines. Sequencing of amplified products and mapping to genomic regions followed by RepeatMasker analysis indicated the presence of transcripts from HERV-W elements previously assumed to be transcriptionally silent due to truncations of the U3-region or complete lack of identifiable 5'-LTR [9, 10]. The presence of such transcripts was subsequently verified by element-specific assays. We suggest that unidentified promoters, direct the expression of such HERV-W elements as has been described for cellular genes [25] in other studies. An analysis of eight different HERV-W gag transcripts previously identified in plasma samples from recent onset schizophrenia patients [26] revealed transcripts from one proviral element, six pseudoelements and one element lacking identifiable HERV-W 5'-LTR. Thus, elements lacking LTR regulatory regions appear to be transcribed in vivo and not only in cell-lines. In the present study, many of the transcribed HERV-W elements which could be mapped to single genomic sites were located in intronic regions of host genes. This is noteworthy as this is the case for only a minority of HERV elements in general [27]. These intronic HERV-W elements were all oriented opposite to the direction of the host gene transcription. Our findings illustrate the importance of detailed characterization of disease-associated transcripts in order to approach the mechanisms underlying their aberrant expression.

We here report that influenza A/WSN/33 can induce an elevation in the levels, to various degrees depending on host cell type, of transcripts related to HERV-W gag and env. The transactivating capacity of infectious agents on retroviral LTRs has previously been documented, e.g. HSV-1 has been reported to transactivate HIV-1 [12]. In vitro, the HIV-1 LTR has been reported to be stimulated also by influenza A virus [14]. Members of the Herpesviridae family can also activate LTRs of endogenous retroviruses including those related to HERV-W [28–30], which is also supported by our present study. Increased expression of HERV-W related envelope protein was also reported in response to HSV-1 but not rabies virus infection in neuroblastoma cells [31]. HSV-1 was recently reported to induce the expression of HERV-W gag protein expression [13].

We find that the mechanisms conferring transcriptional activation of HERV-W elements upon influenza A/WSN/33 virus infection were not related to the antiviral response of cells to either double-stranded RNA or to viral capsid binding and fusion. Induction of cellular stress responses through serum deprivation did however, to some extent, mimic the effects of virus infection in terms of transcription of HERV-W elements. The reported relative sensitivities to serum deprivation of the cell-lines is; U937, CCF-STTG1 and 293F in falling order [16–18]. This sensitivity appears to correlate with the relative increases in HERV-W element transcript levels. Interestingly, in serum deprived 293F cells, despite no discernible influence on the relative amount of HERV-W transcripts, alterations in the relative levels of the transcribed elements were detected. The differences observed in the expression patterns of gag or env transcripts between influenza A/WSN/33 infection and serum deprivation suggest that the virus has specific effects beyond those related to cellular stresses.

Specific analysis of transcripts from 7q21 showed that the proviral element was transactivated by influenza A/WSN/33 virus in all cell-lines tested. Surprisingly, in U937, virus infection elevated the levels of transcripts from elements lacking 5'-U3 regulatory regions. In the other cell types the degree of transactivation was less pronounced. Transcripts from the element lacking identifiable LTR were not even detectable in CCF-STTG1 or 293F cells at either baseline or following infection. Thus, when examined at the individual level, the transcriptional regulation of HERV-W elements is considerably more complex than can be revealed by studying only the promoter activities of HERV-W LTRs.

The proviral element on 7q21, found to be transactivated in all cell-lines studied, contains the only HERV-W gene known to have been "domesticated" into the human genome [32]. The product of this conserved gene is called syncytin in light of its fusogenic activity [11, 33]. Expression of syncytin is normally largely restricted to the placenta, where it is proposed to contribute to the biogenesis of the syncytiotrophoblast layer. In the present study, ectopic expression of syncytin in an astrocytoma cell-line was associated with a lower activity of mitochondrial dehydrogenases as a measure of cytotoxicity. Although the mechanisms mediating this effect remain to be identified, our findings support possible negative influences of ectopically expressed syncytin in multiple sclerosis [34, 35]

That viral insults induce expression of endogenous retroviral sequences raises questions as to the evolutionary origins of this effect. The observed HERV expression could constitute a cellular defense reaction, with syncytin and/or other envelope proteins acting as potential receptor blockers, preventing further spread of the virus in analogy to the protection it offers to Spleen Necrosis Virus infections [36]. This scenario could also be considered a case of a viral hijacking of envelope expression in order to utilize the immunosuppressive properties of the transmembrane region of syncytin (reviewed in [37]). This is further supported by the presence of syncytin at the fetomaternal interface, a region of immunological conflict between mother and foetus [33, 38]. Thus, aberrant syncytin expression could promote immune-system evasion and viral spread, implied indirectly by the fact that syncytin expression is greatly enhanced by virus replication. However, the vast majority of HERV-W elements have no identifiable long ORFs. We speculate that functional consequences of the expression of such sequences should be sought at the level of non-coding RNA (for a review [39]).

The present study gives no evidence of a link between exogenous virus infection and aberrant expression of HERV-W elements in human disease. It does, however, raise some points of relevance for future studies regarding the expression of HERV-W elements;

i) Environmental stressors can modulate the transcriptional activities of certain HERV-W elements which could thereby be markers for such insults. ii) Disease specific frequency distribution patterns of different transcripts need not be reflected in levels of HERV-W transcripts and can be missed by generic methods. iii) Different cell-types exhibit specific quantitative and qualitative differences in the detectable patterns of transcribed HERV-W elements. Thus, transcripts detected in one tissue can differ from those detected in other tissues in response to a common insult. iv) Non-coding HERV-W elements are apparently transcribed which should merit studies into their transcriptional regulation and biological relevance.

Methods

Cell types

Human neuroepithelioma cells, SK-N-MC (HTB-10), were grown in Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (D-MEM/F-12) supplemented with 4 mM L-glutamine, 15 mM HEPES and 12.5% FBS. Human astrocytoma cells, CCF-STTG1 (CRL-1718), and human histiocytic lymphoma cells, U-937 (CRL-1593.2), were grown in RPMI 1640 adjusted to contain 1,5 g/l NaHCO3, 4,5 g/l glucose, 10 mM HEPES and 1.0 mM Na-pyruvate. 293F cells, derived from human kidney, purchased from Invitrogen (Carlsbad, CA), were grown in D-MEM/F-12. All other cell-lines were obtained from the American Type Culture Collection, Manassas, VA. All cell culture media were supplemented with 10% FBS and penicillin/streptomycin (Invitrogen) unless otherwise specified.

Virus infection of cells in culture

SK-N-MC cells, plated 18 hours prior to infection in 6-well tissue culture trays, were rinsed twice with Hank's Balanced Salt Solution w/o Ca2+ or Mg2+ and then duplicate wells were inoculated with MEM 4% FBS without (negative control) or with known amounts (as determined by standard plaque assays) of HSV-1 (102 - 106 plaque forming units (pfu) per well) or influenza A/WSN/33 virus (103 -107 pfu/well). The infections were allowed to proceed for 24 (HSV-1) or 48 hours (influenza A) at 37°C/5% CO2 before RNA isolation, see below.

CCF-STTG1, 293F and U937 cells were washed with one plating volume of MEM and inoculated with MEM containing influenza A/WSN/33 (0.5 MOI) [40]. After 1 hr at 37°C in 5% CO2, cells were washed thrice in one plating volume of MEM. Complete media was added and infections were allowed to proceed for 24 hrs in a humidified 5% CO2 incubator at 37°C before RNA isolation, see below.

Heat-inactivated virus and poly(I:C) treatment

Influenza A/WSN/33 virus was inactivated by heating at 56°C for 90 minutes [41]. CCF-STTG1 cells were washed once in a plating volume of MEM before inoculation as described above with the exception that heat-inactivated virus was also added to the culture medium. Poly(I:C) (Sigma-Aldrich, St. Louis, MO) was dissolved in nuclease-free water (Ambion Inc., Austin, TX) at 10 mg/ml and added to CCF-STTG1 cells at a final concentration of 100 μg/ml [42].

Serum deprivation

CCF-STTG1, 293F and U937 cells were cultured in 35 mm plates with normal growth medium. Cells were washed with one plating volume of their corresponding growth medium without FBS. Cells were subsequently allowed to incubate in another plating volume of serum deprived culture media for 24 hrs in a humidified 5% CO2 incubator at 37°C before RNA isolation, see below.

RNA preparation and reverse transcription

RNA was isolated using the RNeasy Mini kit in accordance with instructions supplied by the manufacturer (Qiagen). RNA was quantified by spectrophotometric analysis. Oligo(dT)-primed cDNA was subsequently generated from 150–500 ng of DNaseI-treated RNA (as previously described [43]) using Superscript II reagents (Invitrogen) according to instructions from the manufacturer. Control reactions without the addition of reverse transcriptase were included.

Real-time PCR and data analysis

1 μl cDNA templates, including the controls generated in the absence of reverse transcriptase, were added to triplicate 25 μl reaction mixtures using Platinum SYBR Green qPCR Supermix UDG (Invitrogen) or TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA) reagents. An ABI Prism 7000 real-time thermocycler (Applied Biosystems) was used for all assays. Oligonucleotides were designed using Primer Express (Applied Biosystems) and ordered from Invitrogen (SYBR Green assays) or Applied Biosystems (TaqMan assay). The sequences of the primers and probes with corresponding design templates are provided in Table 1. The efficiencies of the different assays ranged from 89–91% calculated as previously described [44]. Representative products of each assay were cloned and sequenced as previously described [44]. Threshold cycle (Ct) values from the exponential phase of the PCR amplification plot for each target transcript were normalized to those encoding β-actin. From these values, fold-differences in the levels of transcripts between the two groups were calculated according to the formula 2-ΔΔCt [45]. The non-parametric Mann Whitney test was used to compare the levels of transcripts between cell treatments unless otherwise stated. The melting temperature (Tm) for each amplicon was determined in the ABIprism SDS software (Applied Biosystems) by recording the temperatures corresponding to the maximal rate of dissociation of double-stranded DNA [46]. Analysis was performed through the classification of Tm's into discrete temperature ranges that could reliably be distinguished between assays. Amplicons representative of each of the detected Tm's were cloned and sequenced. Five sequences obtained in the HERV-W gag assay could be mapped to a unique genomic position (Table 2A). Four gag sequences could not be mapped to an exact position due to multiple matches. Similarly, two of the four different W env sequences detected could be mapped to exact positions in the genome (Table 2B). TOPO-TA (Invitrogen) cloning was performed according to the manufacturer's instructions. Plasmids were sequenced at KIseq (Karolinska Institutet) and sequences were aligned with ClustalW http://www.ebi.ac.uk/clustalw/. Mapping of transcribed elements was performed using the BLAT algorithm (http://genome.ucsc.edu/cgi-bin/hgBlat, May 2004 assembly). 4000 bases upstream of uniquely mapped genomic elements were screened by RepeatMasker for the presence of HERV-W family LTRs http://www.repeatmasker.org/cgi-bin/WEBRepeatMasker.
Table 1

Targets, primer and probe sequences and GenBank accession numbers of sequences used for assay design.

Target

Polarity

Sequence (5'-3')

Acc. no.

β-actin

Sense

AACCGCGAGAAATCATGTTTG

AY582799

 

Antisense

CAGAGGCGTACAGGGATAGCA

 

HERV-W env

Sense

CCAATGCATCAGGTGGGTAAC

n/a

 

Antisense

GAGGTACCACAGACAAAAAATATTCCT

 

Syncytin

Sense

GTTAACTTTGTCTCTTCCAGAATCGA

NM_014590

 

Antisense

CATCAGATCGTGGGCTAGCA

 

Interferon-β

Sense

ACCTCCGAAACTGAAGATCTCCTA

NM_002176

 

Antisense

TGCTGGTTGAAGAATGCTTGA

 

11q13 gag

Sense

GTTTGCGGCACCAATCTGT

n/a

 

Antisense

CGATCTCTGGTATCTCAGGTCAATG

 

HSV-1 glycoprotein D

Sense

TTTGCGGAATTGTGTACTGGAT

AY155225

 

Antisense

GAGGCGTATGCGCTTTGG

 

5p13 gag

Sense

CCTGAGGGCCATGACTAAAGAG

n/a

 

Antisense

CCGCCTTAGGCCCAGAGT

 

Seg. 8 A/WSN/33

Sense

CAGCACTCTCGGTCTGGACAT

U13683

 

Antisense

TCCTTCAGAATCCGCTCCACTA

 

HERV-W gag

Sense

TCAGGTCAACAATAGGATGACAACA

n/a

 

Antisense

CAATGAGGGTCTACACTGGGAACT

 

HERV-W 3q26.32 gag ORF, MGB-probe

 

6-FAM-CCTGTGGGAGTTGTT-MGB

AF156961

Table 2

Sequences and genomic positions of mapped HERV-W gag (A) and env (B) elements. Dashes indicate nucleotides that are identical with the prototypical HERV-W sequences. Open circles indicate gaps in sequence. Sequences that could not be unambiguously mapped to one genomic loci are indicated by the number of indistinguishable genomic loci found.

A

   

5' LTR

5' HERV-W gag3'

Tm(°C)

Genomic location (strand)

Truncated

GAGGAAooAGAACAACTCCCooACAGGCCAGCAGGC

80.2

± 0.2

3q26:180256375-180256406(+)

None

-- A---AG-------T----C---------------

80.2

± 0.2

5p13:31432195-31432224(-)

Truncated

---------------T----C--o------------

80.9

± 0.2

12p13:8809216-8809247(-)

None

------AG-------T----C------------A--

79.7

± 0.2

12p12:18113623-18113657(+)

Complete

------AG-------T----CC--------------

80.2

± 0.2

1q42:224124801-224124836(-)

n/a

--------------------C---------------

80.2

± 0.2

2 elements

n/a

------AG-------T----C---------------

80.2

± 0.2

15 elements

n/a

------AG-----G-T----C---------------

80.2

± 0.2

11 elements

n/a

---------------T----C---------------

79.7

± 0.2

4 elements

B

   

5' LTR

5' HERV-W env 3'

Tm(°C)

Genomic location (strand)

n/a

TCCTCCCACACAAATAGTCTGCCTACCCTC

77.6

± 0.2

5 elements

Truncated

---C---o---G------------------

78.1

± 0.2

15q21:53385581-53385607(-)

None

A----------G------------------

78.7

± 0.2

Xq22:106102713-106102742(-)

n/a

-----------G------------------

77.6

± 0.2

5 elements

Mitochondrial viability in response to syncytin expression

CCF-STTG1 cells were transfected with the plasmid PH74 [5] containing the full length ORF encoding syncytin using Lipofectamine 2000 reagents in accordance with the manufacturer's instructions (Invitrogen). Transfection with the pEBFP expression plasmid (Clontech, Mountain View, CA) encoding a variant of green fluorescent protein was used as a control for the effects of forced protein expression. CCF-STTG1 cells were transfected with expression plasmids at 70% confluence in 96-well plates. After 24 hours of incubation at 37°C and 5% CO2, toxicity was determined using the EZ4U kit [47] according to the manufacturer's instructions (Biomedica Medizinprodukte GmbH & Co KG, Wien).

Declarations

Acknowledgements

The present study was generously supported by the Stanley Medical Research Institute, Bethesda, MD and the Swedish Research Council (21X-20047).

Authors’ Affiliations

(1)
The Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
(2)
The Stanley Division of Developmental Neurovirology, The Johns Hopkins University School of Medicine, Baltimore, USA
(3)
UMR 2714 CNRS-bioMérieux, IFR128 BioSciences Lyon-Gerland Ecole Normale Supérieure de Lyon, Lyon cedex 07, France

References

  1. Belshaw R, Katzourakis A, Paces J, Burt A, Tristem M: High Copy Number in Human Endogenous Retrovirus Families is Associated with Copying Mechanisms in Addition to Reinfection. Mol Biol Evol. 2005, 22: 814-817. 10.1093/molbev/msi088.View ArticlePubMedGoogle Scholar
  2. Bannert N, Kurth R: Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A. 2004, 101 Suppl 2: 14572-14579. 10.1073/pnas.0404838101.View ArticlePubMedGoogle Scholar
  3. Seifarth W, Frank O, Zeilfelder U, Spiess B, Greenwood AD, Hehlmann R, Leib-Mosch C: Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J Virol. 2005, 79: 341-352. 10.1128/JVI.79.1.341-352.2005.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Pichon JP, Bonnaud B, Cleuziat P, Mallet F: Multiplex degenerate PCR coupled with an oligo sorbent array for human endogenous retrovirus expression profiling. Nucleic Acids Res. 2006, 34: e46-10.1093/nar/gkl086.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Blond JL, Beseme F, Duret L, Bouton O, Bedin F, Perron H, Mandrand B, Mallet F: Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol. 1999, 73: 1175-1185.PubMed CentralPubMedGoogle Scholar
  6. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B: Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A. 1997, 94: 7583-7588. 10.1073/pnas.94.14.7583.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Karlsson H, Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH: Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci U S A. 2001, 98: 4634-4639. 10.1073/pnas.061021998.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Frank O, Giehl M, Zheng C, Hehlmann R, Leib-Mosch C, Seifarth W: Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J Virol. 2005, 79: 10890-10901. 10.1128/JVI.79.17.10890-10901.2005.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Pavlicek A, Paces J, Elleder D, Hejnar J: Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution. Genome Res. 2002, 12: 391-399. 10.1101/gr.216902. Article published online before print in February 2002.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Costas J: Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W. Mol Biol Evol. 2002, 19: 526-533.View ArticlePubMedGoogle Scholar
  11. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S, Keith JCJ, McCoy JM: Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature. 2000, 403: 785-789. 10.1038/35001608.View ArticlePubMedGoogle Scholar
  12. Palu G, Benetti L, Calistri A: Molecular basis of the interactions between herpes simplex viruses and HIV-1. Herpes. 2001, 8: 50-55.PubMedGoogle Scholar
  13. Ruprecht K, Obojes K, Wengel V, Gronen F, Kim KS, Perron H, Schneider-Schaulies J, Rieckmann P: Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J Neurovirol. 2006, 12: 65-71. 10.1080/13550280600614973.View ArticlePubMedGoogle Scholar
  14. Flory E, Kunz M, Scheller C, Jassoy C, Stauber R, Rapp UR, Ludwig S: Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem. 2000, 275: 8307-8314. 10.1074/jbc.275.12.8307.View ArticlePubMedGoogle Scholar
  15. Morris SJ, Nightingale K, Smith H, Sweet C: Influenza A virus-induced apoptosis is a multifactorial process: exploiting reverse genetics to elucidate the role of influenza A virus proteins in virus-induced apoptosis. Virology. 2005, 335: 198-211. 10.1016/j.virol.2005.02.019.View ArticlePubMedGoogle Scholar
  16. Koo HN, Jeong HJ, Hong SH, Choi JH, An NH, Kim HM: High molecular weight water-soluble chitosan protects against apoptosis induced by serum starvation in human astrocytes. J Nutr Biochem. 2002, 13: 245-249. 10.1016/S0955-2863(01)00218-2.View ArticlePubMedGoogle Scholar
  17. Meinhardt G, Roth J, Totok G, Auner H, Emmerich B, Hass R: Signaling defect in the activation of caspase-3 and PKCdelta in human TUR leukemia cells is associated with resistance to apoptosis. Exp Cell Res. 1999, 247: 534-542. 10.1006/excr.1998.4383.View ArticlePubMedGoogle Scholar
  18. Grimm S, Bauer MK, Baeuerle PA, Schulze-Osthoff K: Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol. 1996, 134: 13-23. 10.1083/jcb.134.1.13.View ArticlePubMedGoogle Scholar
  19. Voisset C, Bouton O, Bedin F, Duret L, Mandrand B, Mallet F, Paranhos-Baccala G: Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family. AIDS Res Hum Retroviruses. 2000, 16: 731-740. 10.1089/088922200308738.View ArticlePubMedGoogle Scholar
  20. Yi JM, Kim HM, Kim HS: Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells. J Gen Virol. 2004, 85: 1203-1210. 10.1099/vir.0.79791-0.View ArticlePubMedGoogle Scholar
  21. Forsman A, Yun Z, Hu L, Uzhameckis D, Jern P, Blomberg J: Development of broadly targeted human endogenous gammaretroviral pol-based real time PCRs Quantitation of RNA expression in human tissues. J Virol Methods. 2005, 129: 16-30. 10.1016/j.jviromet.2005.04.016.View ArticlePubMedGoogle Scholar
  22. Schon U, Seifarth W, Baust C, Hohenadl C, Erfle V, Leib-Mosch C: Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats. Virology. 2001, 279: 280-291. 10.1006/viro.2000.0712.View ArticlePubMedGoogle Scholar
  23. Mallet F, Bouton O, Prudhomme S, Cheynet V, Oriol G, Bonnaud B, Lucotte G, Duret L, Mandrand B: The endogenous retroviral locus ERVWE1 is a bona fide gene involved in hominoid placental physiology. Proc Natl Acad Sci U S A. 2004, 101: 1731-1736. 10.1073/pnas.0305763101.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Prudhomme S, Oriol G, Mallet F: A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression. J Virol. 2004, 78: 12157-12168. 10.1128/JVI.78.22.12157-12168.2004.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Jordan IK, Rogozin IB, Glazko GV, Koonin EV: Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet. 2003, 19: 68-72. 10.1016/S0168-9525(02)00006-9.View ArticlePubMedGoogle Scholar
  26. Karlsson H, Schroder J, Bachmann S, Bottmer C, Yolken RH: HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Mol Psychiatry. 2004, 9: 12-13. 10.1038/sj.mp.4001439.View ArticlePubMedGoogle Scholar
  27. Bushman FD: Targeting survival: integration site selection by retroviruses and LTR-retrotransposons. Cell. 2003, 115: 135-138. 10.1016/S0092-8674(03)00760-8.View ArticlePubMedGoogle Scholar
  28. Lee WJ, Kwun HJ, Kim HS, Jang KL: Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells. 2003, 15: 75-80.PubMedGoogle Scholar
  29. Kwun HJ, Han HJ, Lee WJ, Kim HS, Jang KL: Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex virus type 1 immediate early protein 0. Virus Res. 2002, 86: 93-100. 10.1016/S0168-1702(02)00058-8.View ArticlePubMedGoogle Scholar
  30. Sutkowski N, Chen G, Calderon G, Huber BT: Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol. 2004, 78: 7852-7860. 10.1128/JVI.78.14.7852-7860.2004.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Lafon M, Jouvin-Marche E, Marche PN, Perron H: Human viral superantigens: to be or not to be transactivated?. Trends Immunol. 2002, 23: 238-9; author reply 239. 10.1016/S1471-4906(02)02207-X.View ArticlePubMedGoogle Scholar
  32. Bonnaud B, Bouton O, Oriol G, Cheynet V, Duret L, Mallet F: Evidence of selection on the domesticated ERVWE1 env retroviral element involved in placentation. Mol Biol Evol. 2004, 21: 1895-1901. 10.1093/molbev/msh206.View ArticlePubMedGoogle Scholar
  33. Blond JL, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S, Mandrand B, Mallet F, Cosset FL: An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol. 2000, 74: 3321-3329. 10.1128/JVI.74.7.3321-3329.2000.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Antony JM, van Marle G, Opii W, Butterfield DA, Mallet F, Yong VW, Wallace JL, Deacon RM, Warren K, Power C: Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci. 2004, 7: 1088-1095. 10.1038/nn1319.View ArticlePubMedGoogle Scholar
  35. Perron H, Lazarini F, Ruprecht K, Péchoux-Longin C, Seilhean D, Sazdovitch V, Créange A, Battail-Poirot N, Sibaï G, Santoro L, Jolivet M, Darlix JL, Rieckmann P, Arzberger T, Hauw JJ, Lassmann H: Human endogenous retrovirus (HERV)-W ENV and GAG proteins: Physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J Neurovirol. 2005, 11: 23-33.View ArticlePubMedGoogle Scholar
  36. Ponferrada VG, Mauck BS, Wooley DP: The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus. Arch Virol. 2003, 148: 659-675. 10.1007/s00705-002-0960-x.View ArticlePubMedGoogle Scholar
  37. Lower R, Lower J, Kurth R: The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A. 1996, 93: 5177-5184. 10.1073/pnas.93.11.5177.PubMed CentralView ArticlePubMedGoogle Scholar
  38. Malassine A, Handschuh K, Tsatsaris V, Gerbaud P, Cheynet V, Oriol G, Mallet F, Evain-Brion D: Expression of HERV-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta. Placenta. 2005, 26: 556-562. 10.1016/j.placenta.2004.09.002.View ArticlePubMedGoogle Scholar
  39. Mattick JS, Makunin IV: Non-coding RNA. Hum Mol Genet. 2006, 15 Suppl 1: R17-29. 10.1093/hmg/ddl046.View ArticleGoogle Scholar
  40. Schulman JL, Palese P: Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells. J Virol. 1977, 24: 170-176.PubMed CentralPubMedGoogle Scholar
  41. Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, Katze MG: Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol. 2001, 75: 4321-4331. 10.1128/JVI.75.9.4321-4331.2001.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Chu WM, Ostertag D, Li ZW, Chang L, Chen Y, Hu Y, Williams B, Perrault J, Karin M: JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity. 1999, 11: 721-731. 10.1016/S1074-7613(00)80146-6.View ArticlePubMedGoogle Scholar
  43. Karlsson H, Guthenberg C, von Dobeln U, Kristenssson K: Extraction of RNA from dried blood on filter papers after long-term storage. Clin Chem. 2003, 49: 979-981. 10.1373/49.6.979.View ArticlePubMedGoogle Scholar
  44. Yao Y, Nellaker C, Karlsson H: Evaluation of minor groove binding probe and Taqman probe PCR assays: Influence of mismatches and template complexity on quantification. Mol Cell Probes. 2006Google Scholar
  45. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.View ArticlePubMedGoogle Scholar
  46. Lin MH, Tseng CH, Tseng CC, Huang CH, Chong CK, Tseng CP: Real-time PCR for rapid genotyping of angiotensin-converting enzyme insertion/deletion polymorphism. Clin Biochem. 2001, 34: 661-666. 10.1016/S0009-9120(01)00281-8.View ArticlePubMedGoogle Scholar
  47. Jelinek A, Klocking HP: In vitro toxicity of surfactants in U937 cells: cell membrane integrity and mitochondrial function. Exp Toxicol Pathol. 1998, 50: 472-476.View ArticlePubMedGoogle Scholar

Copyright

© Nellåker et al; licensee BioMed Central Ltd. 2006

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Retrovirology

ISSN: 1742-4690

Contact us